Pharm
Albumin-Bound Paclitaxel
search
Albumin-Bound Paclitaxel
, Protein-Bound Paclitaxel, Abraxane
See Also
Mitotic Inhibitor Chemotherapy
Chemotherapy
Indications
FDA Approved (part of combination protocols)
Non-Small Cell Lung Cancer
(non-operative, not amenable to
Radiation Therapy
)
Pancreatic Cancer
(metastatic)
Breast Cancer
(metastatic, refractory or relapsing)
Off-Label
Metastatic
Melanoma
Ovarian Cancer
or associated cancers (fallopian tube cancer, primary peritoneal cancer)
Contraindications
Hepatic
Impairment
(relative contraindication)
Increased toxicity risk
Mechanism
See
Mitotic Inhibitor Chemotherapy
Albumin-Bound Paclitaxel is a injection formulation of nanoparticles
Removes toxicity inducing solvents, improving
Paclitaxel
safety and
Therapeutic Index
Paclitaxel
is a taxane
Antineoplastic Agent
Derived from extract of the Pacific yew tree (Taxus brevifolia)
Paclitaxel
has antineoplastic activity as a an antitubulin agent
Binds and stabilizes tubulin
Inhibits microtubule disassembly
Results in
Cell Cycle
arrest in G2/M phase
Paclitaxel
induces apoptosis
Binds and blocks apoptosis inhibitor
Protein
Bcl-2 (B-cell
Leukemia
2)
Medications
Protein-Bound Paclitaxel for IV Infusion: 100 mg Vial
Dosing
See other references for disease specific dosing protocols
Adverse Effects
Hypersensitivity Reaction
Myelosuppression (
Bone Marrow
suppression) with
Neutropenia
Peripheral Neuropathy
(sensory)
Future impaired fertility
Alopecia
Cardiac conduction abnormalities
Safety
Avoid in
Lactation
Avoid in pregnancy (all trimesters)
Use reliable
Contraception
Monitoring
Complete Blood Count
Resources
Paclitaxel
Protein
-bound particles for injectable suspension (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4
Paclitaxel
(StatPearls)
https://www.ncbi.nlm.nih.gov/books/NBK536917/
Type your search phrase here